Formulation and Characterization of Diclofenac Sodium Nanogel for Controlled Drug Release

Diclofenac sodium (DFS) is used for treating both inflammation and pain-associated arthritis. Oral administration of DFS is limited by its short half-life. Its use may result in serious gastrointestinal issues, including inflammation, internal bleeding, and ulceration. Novel drug delivery systems ha...

Full description

Saved in:
Bibliographic Details
Published in:Biosciences, biotechnology research Asia biotechnology research Asia, 2024-09, Vol.21 (3), p.967-977
Main Authors: Satyalakshmi, S., Sowjanya, P, Kumari, P. V. Kamala
Format: Article
Language:English
Subjects:
Bioavailability
Diclofenac
Drug delivery
Drug delivery systems
Electron microscopes
Emulsification
Entrapment
Fourier transforms
Inflammation
Metabolism
Nonsteroidal anti-inflammatory drugs
Oral administration
Particle size
Polyethylene glycol
Polymer blends
Scanning electron microscopy
Skin
Sodium
Stability
Viscosity
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Diclofenac sodium (DFS) is used for treating both inflammation and pain-associated arthritis. Oral administration of DFS is limited by its short half-life. Its use may result in serious gastrointestinal issues, including inflammation, internal bleeding, and ulceration. Novel drug delivery systems have been investigated to enhance the bioavailability of DFS. This study focuses on formulating and evaluating a diclofenac sodium nanogel (DNG). A nanogel was produced via a modified emulsification-diffusion process, employing polymers such as eudragit S-100, carbopol-940, and solvents like glycerol and ethylacetate. The properties of formulated DNG, including pH, viscosity, drug content, entrapment efficiency (EE), spreadability, swelling index, and drug release percentage, were evaluated. FTIR spectra confirmed that there is no interaction between the drug and excipients. 7 formulations, F1-F7, have been prepared. The DNG results demonstrated excellent EE, drug release, pH- sensitivity, and stability. 98.9% of drug from glycerin-based nanogels (F2) were released within 8 hours. The kinetic pattern for all formulations was zero-order. This study shows that using nanogel formulation for DNG transdermal delivery can sustain the drug's release for up to 8 hours and have good stability during study period (6 months).
ISSN:0973-1245
2456-2602
DOI:10.13005/bbra/3277